RPL10
Large ribosomal subunit protein uL16
Also known as: DXS648, DXS648E, FLJ23544, L10, NOV, QM, RL10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P27635
- Gene
- RPL10
- Ensembl
- ENSG00000147403
- Chromosome
- X
- Canonical length
- 214 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
This gene encodes a ribosomal protein that is a component of the 60S ribosome subunit. The related protein in chicken can bind to c-Jun and can repress c-Jun-mediated transcriptional activation. Some studies have detected an association between variation in this gene and autism spectrum disorders, though others do not detect this relationship. There are multiple pseudogenes of this gene dispersed throughout the genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
214 residues, UniProt reviewed canonical sequence.
>P27635|RPL10
1 MGRRPARCYR YCKNKPYPKS RFCRGVPDAK IRIFDLGRKK AKVDEFPLCG HMVSDEYEQL
61 SSEALEAARI CANKYMVKSC GKDGFHIRVR LHPFHVIRIN KMLSCAGADR LQTGMRGAFG
121 KPQGTVARVH IGQVIMSIRT KLQNKEHVIE ALRRAKFKFP GRQKIHISKK WGFTKFNADE
181 FEDMVAEKRL IPDGCGVKYI PSRGPLDKWR ALHSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 7,891 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 7,891 nTPM
- ovary: 7,828 nTPM
- tonsil: 4,943 nTPM
- skeletal muscle: 4,611 nTPM
- breast: 4,519 nTPM
- bone marrow: 4,381 nTPM
Single-cell type
- decidual stromal cells: 20,461 nCPM
- esophageal apical cells: 13,891 nCPM
- ovarian stromal cells: 13,873 nCPM
- esophageal suprabasal cells: 13,636 nCPM
- pancreatic acinar cells: 13,164 nCPM
- breast secretory cells: 13,009 nCPM
Immune cell
- total PBMC: 18,216 nTPM
- naive CD4 T-cell: 9,025 nTPM
- memory B-cell: 8,155 nTPM
- MAIT T-cell: 7,792 nTPM
- naive B-cell: 7,735 nTPM
- memory CD4 T-cell: 7,559 nTPM
Brain region
- spinal cord: 814 nTPM
- white matter: 805 nTPM
- medulla oblongata: 723 nTPM
- thalamus: 648 nTPM
- hypothalamus: 629 nTPM
- pons: 593 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RPL10.
Disease | AllUniProt
Conditions RPL10 is implicated in, by any mechanism.
- Autism, X-linked 5 (AUTSX5) MIM:300847
- Intellectual developmental disorder, X-linked, syndromic 35 (MRXS35) MIM:300998
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 144 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, X-linked, syndromic, 35
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 2.61
- DepMap mean gene effect
- -0.88
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytoplasmic translation
- embryonic brain development
- intracellular signal transduction
- negative regulation of transcription by RNA polymerase II
- translation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPL10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL10 as an antibody target. Whether an autoantibody or antibody against RPL10 could matter depends on whether native RPL10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...